PALI
PALISADE BIO, INC.
PALISADE BIO, INC. (PALI) has 9 SEC Form 4 filings (18 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jul 10, 2026.
The most active filer is Director Baltera Robert Jr. with 6 filings. Insiders have net sold $160K over the trailing 6 months.
- Industry:Biotechnology
- CEO:J. D. Finley
- Employees:8
- HQ:Carlsbad, CA, US
- IPO:2007-03-30
Insider Buying
$250K
reported purchases (SEC code P)
Insider Selling
$410K
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$361.0M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Purchase | 20,000 | $40K | Jul 10 | SEC ↗ | |
| Director | Purchase | 25,000 | $49K | Jul 10 | SEC ↗ | |
| Director | Purchase | 20,000 | $41K | Jul 8 | SEC ↗ | |
| Director | Purchase | 30,000 | $61K | Jul 8 | SEC ↗ | |
Jones Mitchell LawrenceFirst filing | Chief Medical Officer | Sale | 51,880 | $107K | Jul 8 | SEC ↗ |
Finley John DavidFirst filing | CEO, CFO | Sale | 146,798 | $303K | Jul 8 | SEC ↗ |
Baltera Robert Jr.First filing | Director | Purchase | 20,000 | $40K | Jul 6 | SEC ↗ |
Baltera Robert Jr.First filing | Director | Purchase | 10,000 | $20K | Jul 6 | SEC ↗ |
Related companies
PALISADE BIO, INC. is in the Healthcare sector.